Avi Livneh

Inserm — France

Biochemistry, Genetics and Molecular Biology · Life Sciences

58h-index13.7kcitations368works0.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Inflammasome and immune disorders(199), Amyloidosis: Diagnosis, Treatment, Outcomes(63), interferon and immune responses(51), Gout, Hyperuricemia, Uric Acid(36), IL-33, ST2, and ILC Pathways(31)

Publications368 total

Phenotypic description of a large French series of individuals with Potocki-Lupski syndrome
Journal of Medical Genetics·2026
Description of the French cohort of ASMD type AB patients
Molecular Genetics and Metabolism·2026Open Access
Non-canonical manifestations of FMF in homozygous M694V MEFV genotype: Insights from a large patient cohort
Seminars in Arthritis and Rheumatism·2025
Renal outcomes and survival in amyloidosis associated with familial Mediterranean fever: A longitudinal study
Seminars in Arthritis and Rheumatism·2025· 2 cited
A single dose of anakinra for arresting familial Mediterranean fever attacks: a proof-of-concept study
Clinical and Experimental Rheumatology·2024Open Access
Diagnostic Challenges and Solutions in Systemic Amyloidosis
International Journal of Molecular Sciences·2023· 13 citedOpen Access
Screening for Fabry’s disease in a high-risk subpopulation of FMF
European journal of medical research·2022· 3 citedOpen Access
Determining the origin of different variants associated with familial mediterranean fever by machine-learning
Scientific Reports·2022· 3 citedOpen Access
The Preferential Use of Anakinra in Various Settings of FMF: A Review Applied to an Updated Treatment-Related Perspective of the Disease
International Journal of Molecular Sciences·2022· 12 citedOpen Access
Safety of the BNT162b2 mRNA COVID-19 vaccine in patients with familial Mediterranean fever
Lara D. Veeken·2022· 9 citedOpen Access
Challenges and insights raised by comorbidity with FMF and selective IgA deficiency
Clinical Immunology Communications·2021· 1 citedOpen Access
Effect of interleukin-1 inhibition in a cohort of patients with colchicine-resistant familial Mediterranean fever treated consecutively with anakinra and canakinumab
Clinical and Experimental Rheumatology·2021· 6 citedOpen Access
Autonomic Nervous System Indices in Patients with Systemic Sclerosis without Overt Cardiac Disease.
PubMed·2021· 2 cited
A Quest to Capture Latent Fabry’s Disease in a High-Risk Subpopulation of FMF.
2021Open Access
Familial Mediterranean fever (FMF)-response to TNF-blockers used for treatment of FMF patients with concurrent inflammatory diseases
Joint Bone Spine·2021· 9 cited
Repolarization dispersion in patients with systemic sclerosis
European Journal of Rheumatology·2020· 5 citedOpen Access
Burden of illness in hereditary periodic fevers: a multinational observational patient diary study.
PubMed·2020· 11 cited
Amyloid storm: acute kidney injury and massive proteinuria, rapidly progressing to end-stage kidney disease in AA amyloidosis of familial Mediterranean fever
Lara D. Veeken·2020· 19 cited
Anakinra for colchicine refractory familial Mediterranean fever: a cohort of 44 patients
Lara D. Veeken·2020· 21 cited
Evaluation of a Proarrhythmic Repolarization Marker (Total Cosine R to T) in Patients With Uncomplicated Familial Mediterranean Fever
JCR Journal of Clinical Rheumatology·2020· 6 cited
page 1 of 19Next →

Frequent Co-authors

Pnina Langevitz(20), Mordechai Pras(11), Yael Shinar(11), Shai Padeh(10), Deborah Zemer(9), Elon Pras(8), Merav Lidar(7), Nurit Zaks(6), Seza Özen(6), Eldad Ben‐Chetrit(5), Marco Gattorno(4), Ahmet Gül(4), Helen J. Lachmann(4), Ruth Gershoni‐Baruch(4), Yackov Berkun(4), Erkan Demirkaya(3), Huri Özdoğan(3), Daniel L. Kastner(3), Joost Frenkel(3), Véronique Hentgen(3)